Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.

PLoS One · 2017 · PMC5363804 · PMID 28333952

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significancep = 0.05actually significant

Secondary efficacy parameters The difference between the OM-85 and the placebo group in SCORAD evolution over time was of borderline significance (p = 0.05) ( Fig 2 ).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.